In 2012, the Federal Trade Commission (FTC) sued Omnicare to block its hostile takeover of its rival PharMerica under federal anti-trust law.
In August 2011, pharmacy services provider Omnicare made a bid of $457 million for all outstanding shares of PharMerica.